ASX:APX Appen (APX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Appen Stock (ASX:APX) 30 days 90 days 365 days Advanced Chart Get Appen alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.01 million shsAverage VolumeN/AMarket CapitalizationA$761.35 millionP/E RatioN/ADividend Yield4.31%Price TargetN/AConsensus RatingN/A Company Overview Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through two segments, Global Services and New Markets. The company provides a platform for the AI data development process. Its platform provides data annotation, such as workflow management and collaboration, data organization, communication, and performance analysis; audio transcription; data collection and categorization; data monitoring; and dataset creation, model performance evaluation, fine-tuning, A/B testing for validation. It offers services including guidance, crowd management, project management, and customized professional services. It serves the healthcare, finance, retail, technology, automotive, media and entertainment, telecommunications and call center, and aerospace and defense industries. The company was formerly known as Appen Holdings Pty Limited and changed its name to Appen Limited in October 2014. Appen Limited was founded in 1996 and is headquartered in Chatswood, Australia. Read More Receive APX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Appen and its competitors with MarketBeat's FREE daily newsletter. Email Address APX Stock News HeadlinesAPX | Appen Ltd. Annual Cash Flow Statement | MarketWatchAugust 11, 2025 | marketwatch.comIs There An Opportunity With Appen Limited's (ASX:APX) 50% Undervaluation?August 5, 2025 | finance.yahoo.comBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.August 18 at 2:00 AM | Smallcaps Daily (Ad)Why is the Appen share price crashing 15%?July 30, 2025 | msn.comAppen Limited's (ASX:APX) top owners are retail investors with 58% stake, while 29% is held by institutionsJune 25, 2025 | finance.yahoo.comHere's Why We're Not At All Concerned With Appen's (ASX:APX) Cash Burn SituationMarch 27, 2025 | finance.yahoo.comASX Market Close: Index pares gains, Gold hits new record | March 18, 2025March 18, 2025 | msn.comChartWatch ASX Scans: Wisetech Global, Lynas Rare Earths, Appen, APA, BetaShares Global Defence ETFMarch 17, 2025 | msn.comSee More Headlines APX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Appen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Appen investors own include Meta Platforms (META), Altium (ALU), CSL (CSL), ImpediMed (IPD), Lynas Rare Earths (LYC), NVIDIA (NVDA) and ZIP (Z1P). Industry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Information Technology Services Sub-IndustryN/A Current SymbolASX:APX CIKN/A Webwww.appen.com Phone61 2 9468 6300FaxN/AEmployees992Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.51Net Income-A$92.52 million Net Margins-37.47% Pretax MarginN/A Return on Equity-111.01% Return on Assets-11.74% Debt Debt-to-Equity Ratio4.53 Current Ratio1.95 Quick Ratio2.17 Sales & Book Value Annual SalesA$247.92 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow46.51 Book ValueA$0.54 per share Price / BookN/AMiscellaneous Outstanding Shares250,330,000Free FloatN/AMarket CapA$761.35 million OptionableNot Optionable Beta1.03 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (ASX:APX) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appen Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Appen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.